دورية
Vitamin D and musculoskeletal health
| العنوان: | Vitamin D and musculoskeletal health |
|---|---|
| المؤلفون: | Wolff, Anne E, Jones, Andrea N, Hansen, Karen E |
| المصدر: | Nature Clinical Practice Rheumatology; November 2008, Vol. 4 Issue: 11 p580-588, 9p |
| مستخلص: | Vitamin D is critical for calcium homeostasis. Following cutaneous synthesis or ingestion, vitamin D is metabolized to 25(OH)D and then to the active form 1,25(OH)2D. Low serum vitamin D levels are common in the general population and cause a decline in calcium absorption, leading to low serum levels of ionized calcium, which in turn trigger the release of parathyroid hormone, promoting skeletal resorption and, eventually, bone loss or osteomalacia. Vitamin D deficiency is generally defined as a serum 25(OH)D concentration <25–37 nmol/l (<10–15 ng/ml), but the definition of the milder state of vitamin D insufficiency is controversial. Three recent meta-analyses concluded that vitamin D must be administered in combination with calcium in order to substantially reduce the risk of nonvertebral fracture in adults over the age of 50 years. Fracture protection is optimal when patient adherence to medication exceeds 80% and vitamin D doses exceed 700 IU/day. In addition to disordered calcium homeostasis, low vitamin D levels might have effects on cell proliferation and differentiation and immune function. Randomized, double-blind, placebo-controlled trials are needed to clarify whether vitamin D supplementation is beneficial in cancer, autoimmune disease and infection. This Review focuses on the pathophysiology, clinical correlates, evaluation and treatment of hypovitaminosis D. |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 17458382 17458390 |
|---|---|
| DOI: | 10.1038/ncprheum0921 |